Literature DB >> 15042600

Purification of the keratan sulfate proteoglycan expressed in prostatic secretory cells and its identification as lumican.

John W Holland1, Katie L Meehan, Sharon L Redmond, Hugh J S Dawkins.   

Abstract

BACKGROUND: Secretory epithelial cells of human prostate contain a keratan sulfate proteoglycan (KSPG) associated with the prostatic secretory granules (PSGs). The proteoglycan has not been identified, but like the PSGs, it is lost in the early stages of malignant transformation.
METHODS: Anion exchange and affinity chromatography were used to purify KSPG from human prostate tissue. Enzymatic deglycosylation was used to remove keratan sulfate (KS). The core protein was isolated using 2D gel electrophoresis, digested in-gel with trypsin, and identified by peptide mass fingerprinting (PMF).
RESULTS: The purified proteoglycan was detected as a broad smear on Western blots with an apparent molecular weight of 65-95 kDa. The KS moiety was susceptible to digestion with keratanase II and peptide N-glycosidase F defining it as highly sulfated and N-linked to the core protein. The core protein was identified, following deglycosylation and PMF, as lumican and subsequently confirmed by Western blotting using an anti-lumican antibody.
CONCLUSIONS: The KSPG associated with PSGs in normal prostate epithelium is lumican. While the role of lumican in extracellular matrix is well established, its function in the prostate secretory process is not known. It's potential to facilitate packaging of polyamines in PSGs, to act as a tumor suppressor and to mark the early stages of malignant transformation warrant further investigation. Copyright 2004 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15042600     DOI: 10.1002/pros.20002

Source DB:  PubMed          Journal:  Prostate        ISSN: 0270-4137            Impact factor:   4.104


  5 in total

Review 1.  Proteoglycans in prostate cancer.

Authors:  Iris J Edwards
Journal:  Nat Rev Urol       Date:  2012-02-21       Impact factor: 14.432

2.  Lumican expression, localization and antitumor activity in prostate cancer.

Authors:  Vivien J Coulson-Thomas; Yvette M Coulson-Thomas; Tarsis F Gesteira; Claudia A Andrade de Paula; Celia R W Carneiro; Valdemar Ortiz; Leny Toma; Winston W-Y Kao; Helena B Nader
Journal:  Exp Cell Res       Date:  2013-02-08       Impact factor: 3.905

3.  Texas 3-step decellularization protocol: looking at the cardiac extracellular matrix.

Authors:  Lisandra E de Castro Brás; Trevi A Ramirez; Kristine Y DeLeon-Pennell; Ying Ann Chiao; Yonggang Ma; Qiuxia Dai; Ganesh V Halade; Kevin Hakala; Susan T Weintraub; Merry L Lindsey
Journal:  J Proteomics       Date:  2013-05-14       Impact factor: 4.044

4.  Proteoglycan expression in normal human prostate tissue and prostate cancer.

Authors:  Anastasia V Suhovskih; Lyudmila A Mostovich; Igor S Kunin; Mekhrozhiddin M Boboev; Galina I Nepomnyashchikh; Svetlana V Aidagulova; Elvira V Grigorieva
Journal:  ISRN Oncol       Date:  2013-04-18

Review 5.  Keratan sulfate, a complex glycosaminoglycan with unique functional capability.

Authors:  Bruce Caterson; James Melrose
Journal:  Glycobiology       Date:  2018-04-01       Impact factor: 4.313

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.